To continue the extraordinary progress of the past fifteen years, the next U.S. administration should further integrate global health, development, and pandemic preparedness into the U.S. national security architecture.
Joshua Sharfstein of Johns Hopkins Bloomberg School of Public Health and Alex Tabarrok of George Mason University join CFR’s Thomas Bollyky to discuss the role that generic drug regulation might play in addressing off-patent pharmaceutical pricing concerns.
For the past three years, the Global Health program at the Council on Foreign Relations has been tracking news reports to produce an interactive map plotting global outbreaks of diseases that are easily prevented by inexpensive and effective vaccines.
Experts review case studies that frame the complexities of the food and drug supply chains and the policies which need to be addressed in order to protect consumers from fraud and food outbreaks.
This session was part of CFR's Symposium on Food and Drugs: Can Safety Be Ensured in a Time of Increased Globalization? which was sponsored by CFR's International Institutions and Global Governance Program and made possible through generous support from the Robina Foundation.